Sort by: Helpfulness | Most Recent
1 patient evaluation for Carbidopa-Levodopa CR taken for the purpose of 'Parkinson's Disease' with a perceived effectiveness rating of Moderate
|Date||Dosage||Parkinson's Disease Perceived effectiveness||Insomnia Perceived effectiveness||Side Effects||Adherence||Burden|
|Jun 06, 2010||50 mg-200 mg Daily||Moderate||Moderate||None||Always||Not at all|
|Nov 09, 2009||50 mg-200 mg Daily||Moderate||Slight||None||Always||Not at all|
12 additional evaluations for Carbidopa-Levodopa CR are not currently shared publicly.